Please Upload related files below
Fill in below.
Tell us the stocks you own using Snaptrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. Snaptrade only shares the tickers you own and your transaction history, not your account numbers. Using Snaptrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery- link your account with Snaptrade.
On March 28, 2023, Scorpion Capital published a report detailing a string of concerns with Harmony’s narcolepsy drug, Wakix (pitolisant). The report raised numerous concerns related to patient health, drug efficacy, and trial reliability, as well as allegations the Company engaged in price-gouging, false advertising, and a significant off-label and physician kickback scheme.
Following this news, Harmony’s stock price fell by $10.70 per share to close at $30.80 per share.